SCHEMBL3759712

SCHEMBL3759712

Fc1cccc(-c2csc(N3CCNCC3)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
AR P10275 7/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
HSD17B10 Q99714 2/20 0.51
TP53 P04637 1/20 0.51
ALOX15 P16050 1/20 0.51
FAAH O00519 1/20 0.51
RAB9A P51151 4/20 0.50
NPC1 O15118 2/20 0.50
HTR1A P08908 2/20 0.50
HTR1D P28221 2/20 0.50
HTR2A P28223 2/20 0.50
HTR7 P34969 2/20 0.50
HTR2B P41595 2/20 0.50
HTR6 P50406 2/20 0.50
HTR1B P28222 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767451 0.86 AR (0.69) MAPTKDM4EMEN1KMT2AAR
Hydrochloric Acid SCHEMBL3767893 0.85 AR (0.68) MAPTKDM4EMEN1KMT2AAR
SCHEMBL3771000 0.84 AR (0.51) MAPTKDM4EMEN1KMT2AAR
SCHEMBL3761156 0.84 RAB9A (0.63) MAPTMEN1KMT2AARSMN1; SMN2
SCHEMBL3767441 0.84 AR (0.74) MAPTKDM4EMEN1KMT2AAR
SCHEMBL194798 0.83 L3MBTL1 (0.72) MAPTMEN1KMT2AARSMN1; SMN2
SCHEMBL2710025 0.83 AR (0.72) MAPTKDM4EMEN1KMT2AAR
Hydrochloric Acid SCHEMBL3777109 0.82 L3MBTL1 (0.70) MAPTMEN1KMT2AARSMN1; SMN2
Hydrochloric Acid SCHEMBL3766425 0.82 L3MBTL1 (0.70) MAPTMEN1KMT2AARSMN1; SMN2
SCHEMBL3768189 0.82 CTSL (0.52) MAPTKMT2AARSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
CN-101103007-A Amide compound TAKEDA PHARMACEUTICAL (JP) 2008-01-09 CN disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 MAPT 3805/4885KDM4E 1547/4885MEN1 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.